NO20061513L - Kondensert ringforbindelse og anvendelse derav - Google Patents
Kondensert ringforbindelse og anvendelse deravInfo
- Publication number
- NO20061513L NO20061513L NO20061513A NO20061513A NO20061513L NO 20061513 L NO20061513 L NO 20061513L NO 20061513 A NO20061513 A NO 20061513A NO 20061513 A NO20061513 A NO 20061513A NO 20061513 L NO20061513 L NO 20061513L
- Authority
- NO
- Norway
- Prior art keywords
- sinusitis
- chronic
- compound
- condensed ring
- ring compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 abstract 2
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 abstract 1
- 206010001076 Acute sinusitis Diseases 0.000 abstract 1
- 206010006458 Bronchitis chronic Diseases 0.000 abstract 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 206010009137 Chronic sinusitis Diseases 0.000 abstract 1
- 208000029523 Interstitial Lung disease Diseases 0.000 abstract 1
- 206010035664 Pneumonia Diseases 0.000 abstract 1
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 230000000954 anitussive effect Effects 0.000 abstract 1
- 239000003434 antitussive agent Substances 0.000 abstract 1
- 229940124584 antitussives Drugs 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 208000007451 chronic bronchitis Diseases 0.000 abstract 1
- 208000027157 chronic rhinosinusitis Diseases 0.000 abstract 1
- 239000003172 expectorant agent Substances 0.000 abstract 1
- 230000003419 expectorant effect Effects 0.000 abstract 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 201000009890 sinusitis Diseases 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/59—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
- C07C205/60—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms in ortho-position to the carboxyl group, e.g. nitro-salicylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/36—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
- C07C205/37—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003309232 | 2003-09-01 | ||
| JP2003369547 | 2003-10-29 | ||
| PCT/JP2004/012563 WO2005021518A1 (ja) | 2003-09-01 | 2004-08-31 | 縮環化合物およびその用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20061513L true NO20061513L (no) | 2006-06-01 |
Family
ID=34277677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20061513A NO20061513L (no) | 2003-09-01 | 2006-04-03 | Kondensert ringforbindelse og anvendelse derav |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7763610B2 (de) |
| EP (2) | EP1661892B1 (de) |
| JP (1) | JP4720502B2 (de) |
| KR (1) | KR101135911B1 (de) |
| AU (1) | AU2004268865B8 (de) |
| BR (1) | BRPI0413968A (de) |
| CA (1) | CA2537355C (de) |
| ES (1) | ES2425746T3 (de) |
| IL (1) | IL173898A (de) |
| MX (1) | MXPA06002152A (de) |
| NO (1) | NO20061513L (de) |
| NZ (1) | NZ545666A (de) |
| RU (1) | RU2371436C2 (de) |
| WO (1) | WO2005021518A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ560513A (en) | 2005-02-25 | 2010-07-30 | Ono Pharmaceutical Co | Indole compound and use thereof |
| TWI406664B (zh) * | 2006-03-30 | 2013-09-01 | Univ Kyoto | 硫氧還蛋白（ｔｈｉｏｒｅｄｏｘｉｎ）產生促進劑 |
| TWI469965B (zh) * | 2008-12-22 | 2015-01-21 | Ono Pharmaceutical Co | 乙炔基吲哚化合物 |
| MY162757A (en) * | 2010-06-21 | 2017-07-14 | Ono Pharmaceutical Co | New Crystalline Forms of 4,4’-[4-Fluoro-7-({4-[4-(3-Fluoro-2-Methylphenyl) Butoxy] Phenyl}Ethynyl)-2-Methyl-1H-Indole-1, 3-Diyl] Dibutanoic Acid |
| WO2013066838A1 (en) * | 2011-10-31 | 2013-05-10 | Glaxosmithkline Llc | Compounds and methods |
| US9603907B2 (en) | 2012-02-01 | 2017-03-28 | Protalix Ltd. | Dry powder formulations of dNase I |
| WO2016057693A1 (en) | 2014-10-10 | 2016-04-14 | Alnylam Pharmaceuticals, Inc. | Methods and compositions for inhalation delivery of conjugated oligonucleotide |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE555319A (de) | 1956-03-21 | 1900-01-01 | ||
| US3095355A (en) | 1961-10-12 | 1963-06-25 | Revlon | Aerosol composition |
| US4618361A (en) * | 1983-12-12 | 1986-10-21 | Ciba-Geigy Corporation | Acylamides and compositions for the protection of cultivated plants against the phytotoxic action of herbicides |
| CA1261835A (en) * | 1984-08-20 | 1989-09-26 | Masaaki Toda | (fused) benz(thio)amides |
| CA2019335C (en) | 1989-06-27 | 2000-08-01 | Mitoshi Konno | Phenylalkan (en)oic acids |
| GB8916774D0 (en) * | 1989-07-21 | 1989-09-06 | Bayer Ag | New indole derivatives,a process for their preparation and their use in medicaments |
| US5468898A (en) * | 1990-09-10 | 1995-11-21 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted naphthylene compounds exhibiting selective leukotriene B4 antagonist activity |
| US5696117A (en) * | 1995-11-07 | 1997-12-09 | Ortho Pharmaceutical Corporation | Benzoxazine antimicrobial agents |
| GB9523946D0 (en) | 1995-11-23 | 1996-01-24 | Bayer Ag | Leukotriene antagonistic benzoic acid derivatives |
| FR2766824B1 (fr) | 1997-07-30 | 1999-09-10 | Adir | Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| CN101284773A (zh) * | 2001-08-09 | 2008-10-15 | 小野药品工业株式会社 | 羧酸衍生物及以它为活性成分的药剂 |
| US20040072802A1 (en) * | 2002-10-09 | 2004-04-15 | Jingwu Duan | Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha |
| DE10257785A1 (de) | 2002-12-11 | 2004-07-01 | Bayer Healthcare Ag | Isophthalsäurederivate |
-
2004
- 2004-08-31 JP JP2005513507A patent/JP4720502B2/ja not_active Expired - Fee Related
- 2004-08-31 ES ES04772519T patent/ES2425746T3/es not_active Expired - Lifetime
- 2004-08-31 RU RU2006110513/04A patent/RU2371436C2/ru not_active IP Right Cessation
- 2004-08-31 EP EP04772519.7A patent/EP1661892B1/de not_active Expired - Lifetime
- 2004-08-31 NZ NZ545666A patent/NZ545666A/en not_active IP Right Cessation
- 2004-08-31 EP EP12152985A patent/EP2481732A1/de not_active Withdrawn
- 2004-08-31 BR BRPI0413968-2A patent/BRPI0413968A/pt not_active Application Discontinuation
- 2004-08-31 WO PCT/JP2004/012563 patent/WO2005021518A1/ja not_active Ceased
- 2004-08-31 MX MXPA06002152A patent/MXPA06002152A/es active IP Right Grant
- 2004-08-31 AU AU2004268865A patent/AU2004268865B8/en not_active Ceased
- 2004-08-31 US US10/569,482 patent/US7763610B2/en not_active Expired - Fee Related
- 2004-08-31 CA CA2537355A patent/CA2537355C/en not_active Expired - Fee Related
- 2004-08-31 KR KR1020067004215A patent/KR101135911B1/ko not_active Expired - Fee Related
-
2006
- 2006-02-23 IL IL173898A patent/IL173898A/en not_active IP Right Cessation
- 2006-04-03 NO NO20061513A patent/NO20061513L/no not_active Application Discontinuation
-
2010
- 2010-06-01 US US12/791,365 patent/US8318952B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US8318952B2 (en) | 2012-11-27 |
| US7763610B2 (en) | 2010-07-27 |
| EP1661892A4 (de) | 2009-02-18 |
| IL173898A0 (en) | 2006-07-05 |
| JPWO2005021518A1 (ja) | 2007-11-01 |
| BRPI0413968A (pt) | 2006-10-31 |
| AU2004268865B8 (en) | 2011-01-06 |
| MXPA06002152A (es) | 2006-05-22 |
| WO2005021518A1 (ja) | 2005-03-10 |
| AU2004268865A1 (en) | 2005-03-10 |
| CA2537355A1 (en) | 2005-03-10 |
| EP2481732A1 (de) | 2012-08-01 |
| ES2425746T3 (es) | 2013-10-17 |
| RU2371436C2 (ru) | 2009-10-27 |
| AU2004268865B2 (en) | 2010-12-16 |
| KR20060119903A (ko) | 2006-11-24 |
| US20060194797A1 (en) | 2006-08-31 |
| CA2537355C (en) | 2012-10-09 |
| EP1661892B1 (de) | 2013-07-24 |
| JP4720502B2 (ja) | 2011-07-13 |
| RU2006110513A (ru) | 2007-10-10 |
| KR101135911B1 (ko) | 2012-04-16 |
| EP1661892A1 (de) | 2006-05-31 |
| IL173898A (en) | 2012-03-29 |
| US20100234368A1 (en) | 2010-09-16 |
| NZ545666A (en) | 2009-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20082000L (no) | Pyrimidinamidforbindelser som PGDS-inhibitorer | |
| BRPI0606870A2 (pt) | composto de indol e uso do mesmo | |
| NO20084005L (no) | Aminderivater | |
| BR0107934A (pt) | Carboxamidas de pirimidina úteis como inibidores de isozimas pde4 | |
| NO20083562L (no) | Cannabinoidreseptormodulatorer | |
| NO20082026L (no) | Deazapuriner som er nyttige som inhibitorer for Janus-kinaser | |
| NO20061254L (no) | Farmasoytiske blandinger | |
| NO20082124L (no) | Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom | |
| MX2009009443A (es) | Compuestos de pirimidina hidrazida como inhibidores de pgds. | |
| NO20063693L (no) | Forbindelse og metode for anvendelse | |
| NO20073831L (no) | Medikamenter for behandling eller forebygging av fibrotiske sykdommer | |
| WO2010042163A3 (en) | Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders | |
| NO20082090L (no) | Pyridopyrimidinoninhibitorer av P13K alfa | |
| BRPI0507041A (pt) | composto derivados de sulfonamida para o tratamento de doenças seus usos, processo para a preparação dos compostos e combinação de compostos | |
| CY1108900T1 (el) | Πολυθειωμενα γλυκοζιδια και αλατα αυτων | |
| NO20070588L (no) | Piperidinderivater som NK1-antagonister. | |
| NO20081014L (no) | Sammensetninger | |
| NO20061513L (no) | Kondensert ringforbindelse og anvendelse derav | |
| NO20070076L (no) | Nye indazolkarboksamider og deres anvendelse | |
| NO20080457L (no) | Kjemiske forbindelser | |
| WO2007114848A3 (en) | Chemical compounds | |
| NO20081480L (no) | Kombinasjon av forbindelser som kan brukes ved behandling av respiratoriske sykdommer, spesielt kronisk obstruktiv pulmonaer sykdom (COPD) og astma | |
| MX2009013926A (es) | Compuestos de etinilindol. | |
| NO20065022L (no) | Substituerte 4-alkyl- og 4-alkanoyl-piperidinderivater og deres anvendelse som neurokininantagonister | |
| NO20065757L (no) | Purinderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |